ghk-cu doses Dosage: Clinical Guidance for Safe Administration – PlexusDx GHK-Cu Dosing: 1.7mg/Day Injectable (2026)

It is supplied solely for laboratory research and is not approved for human, veterinary, or clinical use

Dose reduction community sources describe halving the per-injection dose when flushing or metallic taste becomes too intrusive, then re-evaluating at 2 weeks

Formulators can use GHK-Cu to create high-performance anti-aging products that deliver visible results

Geroprotection (Kidney & Muscle) Studies in aged mice demonstrate that SLU-PP-332 reverses podocyte loss in the kidney and reduces albuminuria

This antioxidant supports the livers ability to process and eliminate toxins, aiding in a clearer, more radiant complexion